Imagene AI
Latest round
- Seed
Last raised
- May 2022
Total raised
- Undisclosed
Investors
- 1
About Imagene AI
, offers molecular screening for research and clinical practice. In May 2022, Imagene AI Ltd. In July 2025, Imagene AI Ltd. The firm offers AI-based molecular biomarkers and genomic detection which provide real-time insights from the biopsy image. The company’s molecular and micro-environment platform can scan patients' histological data for personalized therapy. Additionally, the company helps in the drug development process and optimizing the patient’s treatment plan.
Who invested in Imagene AI
1 investor across 1 round
See all investors in Imagene AI
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 2, 2022
Amount
Undisclosed
Investors
Questions about Imagene AI
Who invested in Imagene AI?
Imagene AI has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Imagene AI raised?
Imagene AI has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Imagene AI last raise money?
Imagene AI's most recent round on record is a Seed, in May 2022.
What does Imagene AI do?
, offers molecular screening for research and clinical practice.
Where is Imagene AI headquartered?
Imagene AI is headquartered in Miami Beach, US.
Which VCs invest in companies like Imagene AI?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Imagene AI's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Imagene AI? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.